Spatial Repellents for Aedes-borne Virus Control in Sri Lanka (AEGIS ABV)
A Cluster Randomized, Placebo Control Trial to Evaluate the Efficacy of a Spatial Repellent (Mosquito ShieldTM) Against Aedes-borne Virus Infection Among Children ≥ 4-16 Years of Age in the Gampaha District, Sri Lanka
Sponsor: Ministry of Health, Sri Lanka
A NA clinical study on Arbovirus Infections, this trial is completed. The trial is conducted by Ministry of Health, Sri Lanka and has accumulated 8 data snapshots since 2023. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2025 — Oct 2025 [monthly]
Recruiting NA
-
May 2025 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2023 — Jan 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Health, Sri Lanka
- RemediumOne
- S.C. Johnson & Son, Inc.
- University of Notre Dame
- University of Sri Jayewardenepura, Sri Lanka
- University of Washington
- fhiClinical
For direct contact, visit the study record on ClinicalTrials.gov .